Stipani V, Cappello A R, Daddabbo L, Natuzzi D, Miniero D V, Stipani I, Palmieri F
Department of Pharmaco-Biology, Laboratory of Biochemistry and Molecular Biology, University of Bari, 70125 Bari, Italy.
Biochemistry. 2001 Dec 25;40(51):15805-10. doi: 10.1021/bi011616j.
Using a functional mitochondrial oxoglutarate carrier mutant devoid of Cys residues (C-less carrier), each amino acid residue in transmembrane domain IV and flanking hydrophilic loops (from T179 to S205) was replaced individually with Cys. The great majority of the 27 mutants exhibited significant oxoglutarate transport in reconstituted liposomes as compared to the activity of the C-less carrier. In contrast, Cys substitution for G183, R190, Q198, and Y202, in either C-less or wild-type carriers, yielded molecules with complete loss of oxoglutarate transport activity. G183 and R190 could be partially replaced only by Ala and Lys, respectively, whereas Q198 and Y202 were irreplaceable with respect to oxoglutarate transport. Of the single-Cys mutants tested, only T187C, A191C, V194C, and N195C were strongly inactivated by N-ethylmaleimide and by low concentrations of methanethiosulfonate derivatives. Oxoglutarate protects Cys residues at positions 187, 191, and 194 against reaction with N-ethylmaleimide. These positions as well as the residues found to be essential for the carrier activity, except Y202 which is located in the extramembrane loop IV-V, reside on the same face of transmembrane helix IV, probably lining part of a water-accessible crevice or channel between helices of the oxoglutarate carrier.
使用不含半胱氨酸残基的功能性线粒体氧代戊二酸载体突变体(无半胱氨酸载体),跨膜结构域IV及相邻亲水环(从T179至S205)中的每个氨基酸残基都被单独替换为半胱氨酸。与无半胱氨酸载体的活性相比,这27个突变体中的绝大多数在重构脂质体中表现出显著的氧代戊二酸转运活性。相反,在无半胱氨酸或野生型载体中,将半胱氨酸取代G183、R190、Q198和Y202,产生的分子完全丧失了氧代戊二酸转运活性。G183和R190只能分别被丙氨酸和赖氨酸部分取代,而Q198和Y202对于氧代戊二酸转运是不可替代的。在所测试的单半胱氨酸突变体中,只有T187C、A191C、V194C和N195C被N-乙基马来酰亚胺和低浓度的甲硫代磺酸酯衍生物强烈灭活。氧代戊二酸可保护187、191和194位的半胱氨酸残基不与N-乙基马来酰亚胺发生反应。这些位置以及被发现对载体活性至关重要的残基,除了位于膜外环IV-V中的Y202外,都位于跨膜螺旋IV的同一面上,可能构成了氧代戊二酸载体螺旋之间水可及的裂缝或通道的一部分。